newsfilter
← Latest News
GlobeNewswire·

China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency

TAIZHOU, China, March 17, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) (the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing,